Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.12DKK
10:50am EDT
Price Change (% chg)

kr.0.02 (+0.49%)
Prev Close
kr.4.10
Open
kr.4.10
Day's High
kr.4.20
Day's Low
kr.4.10
Volume
33,871
Avg. Vol
52,750
52-wk High
kr.8.50
52-wk Low
kr.2.66

NEUR.CO

Chart for NEUR.CO

About

NeuroSearch A/S is Denmark-based biopharmaceutical company. It is primarily engaged in the Research and Development, registration, marketing and sale of treatments for diseases and disorders affecting the Central Nervous System (CNS), such as Huntington’s, Parkinson’s and Alzheimer’s diseases, as well as pain, epilepsy and... (more)
No analyst recommendations are available for NEUR.CO.

Overall

Beta: 1.84
Market Cap (Mil.): kr.100.67
Shares Outstanding (Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): -- 44.65 37.87
EPS (TTM): -13.98 -- --
ROI: -100.39 -2.30 18.70
ROE: -165.76 -2.12 19.53
Search Stocks

BRIEF-Neurosearch gives notice to CEO

STOCKHOLM, July 31 - Neurosearch A/S : * Gives notice to CEO * Says notice a consequence of strategy to wind up company's activities and to

31 Jul 2013

BRIEF-Neurosearch to start talks on cutting majority of staff

STOCKHOLM, March 18 - Neurosearch A/S : * Says transfer of the Huntexil project to Teva Pharmaceutical Industries LTD.

18 Mar 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00
Provider: GlobalData
$250.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks